Cardiology (all articles)
Cohort Study: Characteristics and outcomes of Type 2 myocardial infarction.
18 Mar, 2022 | 08:05h | UTCCharacteristics and Outcomes of Type 2 Myocardial Infarction – JAMA Cardiology (link to abstract – $ for full-text)
Commentaries:
Type 2 MI Not Uncommon in the Emergency Department – TCTMD
Type 2 Myocardial Infarction: Clinical Characteristics and Outcomes – American College of Cardiology
Commentary on Twitter
Among patients presenting with acute chest discomfort to the emergency department, tachyarrhythmias and hypertension are responsible for more than two thirds of type 2 myocardial infarction and result in a lower mortality compared to other triggers. https://t.co/ODMCmOjeQO
— JAMA Cardiology (@JAMACardio) March 10, 2022
The identification and management of high blood pressure using exercise blood pressure: current evidence and practical guidance.
18 Mar, 2022 | 07:57h | UTC
2022 ACC expert consensus decision pathway on cardiovascular sequelae of COVID-19 in adults: myocarditis and other myocardial involvement, post-acute sequelae of SARS-CoV-2 infection, and return to play.
17 Mar, 2022 | 09:26h | UTCCommentaries:
ACC Issues Clinical Guidance on CV Consequences of COVID-19 – American College of Cardiology
ACC Releases Guidance on CV Issues With COVID-19 – TCTMD
Key Points: 2022 ACC Decision Pathway on Cardiovascular Sequelae of COVID-19
Related:
Review | Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus.
The pathogenesis and long-term consequences of Covid-19 cardiac injury: state-of-the-art review.
COVID-19 infections increase risk of heart conditions up to a year later, study finds.
Commentary on Twitter (thread – click for more)
Access the full ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocarditis and Other Myocardial Involvement, Post-acute Sequelae of SARS-CoV-2 Infection, and Return to Play: https://t.co/ph75qZxfpT #JACC @JACCJournals #CardioTwitter (8/8) pic.twitter.com/mpYJic6gem
— American College of Cardiology (@ACCinTouch) March 16, 2022
[News release – not published yet] Empagliflozin phase III EMPA-KIDNEY trial will stop early due to evidence of efficacy in people with chronic kidney disease.
17 Mar, 2022 | 09:07h | UTC
Commentary on Twitter
Details of the design & pt characteristics now published:
6609 people from 8 countries
(UK, Germany, Italy, USA, Canada, China, Malaysia, Japan)
Mean age 64 years
1/3 female
1/2 diabetes; 1/2 without
3/4 eGFR <45 mL/min/1.73 m2.
1/2 uACR <300 mg/g https://t.co/jOD8kyp3i4 pic.twitter.com/YYpGPJDnV9— Martin Landray (@MartinLandray) March 16, 2022
Malignant Hypertension: Current perspectives and challenges.
17 Mar, 2022 | 09:03h | UTC
Open-Label, multicenter study of Flecainide Acetate oral inhalation solution for acute conversion of recent-onset, symptomatic atrial fibrillation to sinus rhythm.
17 Mar, 2022 | 09:01h | UTC
Commentary on Twitter
Inhalation of flecainide simply converts many episodes of recent onset atrial fibrillation #AHAJournals #HeartMonthhttps://t.co/vNXx4fKy2u pic.twitter.com/UNGA9DX3qM
— CircEP (@CirculationEP) February 25, 2022
Position Paper: Multi-modality imaging assessment of native valvular regurgitation.
17 Mar, 2022 | 08:49h | UTC
Review: Mechanistic and clinical overview of cardiovascular toxicity with BRAF and MEK inhibitors.
17 Mar, 2022 | 08:34h | UTC
Commentary on Twitter
New #JACCCardioOnc issue is out!
BRAF/MEK inhibitors are associated w/ adverse CV effects including HTN, LV dysfunction, #VTE, atrial arrhythmias, & QT prolongation. Learn more in this state-of-the-art review: https://t.co/2r9L90DTmL#CardioOnc #CardioTwitter #Hypertension pic.twitter.com/Dz8i0sfBTU
— JACC Journals (@JACCJournals) March 15, 2022
Retrospective Cohort Study: Association of donor brain death due to stroke with prognosis after heart transplantation.
17 Mar, 2022 | 08:33h | UTCAssociation of Donor Brain Death Due to Stroke With Prognosis After Heart Transplantation – Journal of the American College of Cardiology (link to abstract – $ for full-text)
Commentaries:
Young Stroke Victims’ Hearts Might Not Be as Good for Transplantation – MedPage Today
Commentary on Twitter
🔑 Takeaway: #Stroke as the cause of donor brain death compared to all other causes of brain death was not associated w/ increased mortality or allograft failure in heart transplant recipients. Read more: https://t.co/NynBVsQSqh #cvSurg #cvHCM @MartyTamMD
— American College of Cardiology (@ACCinTouch) March 16, 2022
Cohort Study: Incident cardiovascular disease among adults with cancer.
17 Mar, 2022 | 08:10h | UTCCommentaries:
New Cancer Diagnosis May Up Risk for CV Death, Morbidity – HealthDay
What is the Incidence of CVD Among Adults With Cancer? – American College of Cardiology
Commentary on Twitter
A new cancer diagnosis may be independently associated with a "significantly higher risk" for cardiovascular death, #stroke, #HeartFailure, and pulmonary embolism, especially in the first year, according to a study in #JACCCardioOnc. https://t.co/XboZ2Ivsdl @JACCJournals
— American College of Cardiology (@ACCinTouch) March 16, 2022
Review: Role of imaging in rare COVID-19 vaccine multiorgan complications.
16 Mar, 2022 | 10:00h | UTCRole of imaging in rare COVID-19 vaccine multiorgan complications – Insights into Imaging
Cohort Study | Breast arterial calcification: a novel cardiovascular risk enhancer among postmenopausal women.
16 Mar, 2022 | 09:56h | UTCBreast Arterial Calcification: a Novel Cardiovascular Risk Enhancer Among Postmenopausal Women – Circulation: Cardiovascular Imaging (link to abstract – $ for full-text)
News Release: Mammograms may provide clues about women’s risk for cardiovascular disease – AHA Newsroom
Commentaries:
More Evidence Links Breast Arterial Calcification and CVD Risk – TCTMD
Breast Arterial Calcification on Mammography Tied to CVD Risk – HealthDay
Related: Review: Role of Breast Arterial Calcification for Cardiovascular Risk Stratification in Women
Review: Design variation, implantation, and outcome of transcatheter mitral valve prosthesis.
16 Mar, 2022 | 08:43h | UTC
M-A: Evaluating the association between LDL Cholesterol reduction and relative and absolute effects of statin treatment.
15 Mar, 2022 | 10:04h | UTCEvaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment: A Systematic Review and Meta-analysis – JAMA Internal Medicine (free for a limited period)
Commentary from the author: Benefits of statins may have been overstated – new study – The Conversation
Commentary on Twitter
Our study in @JAMAInternalMed asked 2 questions 1. Is reducing one’s ‘bad’ cholesterol was associated with a proportional reduction in death, heart attack and stroke? 2. What's the absolute reduction in risk from taking statins? https://t.co/Zwh7LmUD0e
— Dr Paula Byrne (@pbyrne82) March 14, 2022
Cohort Study: Evaluating rates of recurrent ischemic stroke among young adults with embolic stroke of undetermined source.
15 Mar, 2022 | 08:33h | UTCEvaluating Rates of Recurrent Ischemic Stroke Among Young Adults With Embolic Stroke of Undetermined Source: The Young ESUS Longitudinal Cohort Study – JAMA Neurology (free for a limited period)
Commentary: Embolic Stroke of Undetermined Source in the Young: Low Recurrence, but Few Answers — Growing evidence that role of atrial fibrillation is less important than originally believed – MedPage Today (free registration required)
Commentary on Twitter
Study found relatively low rate of subsequent ischemic stroke and new onset #AF in young patients with ESUS compared to older patients. History of stroke/TIA, diabetes, and coronary artery disease were predictive of recurrence. https://t.co/mzTgMkVFGN @PereraKanjana
— JAMA Neurology (@JAMANeuro) March 14, 2022
Review: Diagnosis and management of postural orthostatic tachycardia syndrome.
15 Mar, 2022 | 08:26h | UTC
Cohort studies show an independent association of Lipoprotein(a) and coronary artery calcification with atherosclerotic cardiovascular risk.
15 Mar, 2022 | 08:28h | UTCIndependent Association of Lipoprotein(a) and Coronary Artery Calcification With Atherosclerotic Cardiovascular Risk – Journal of the American College of Cardiology (link to abstract – $ for full-text)
Podcast: Cardiorenal Syndrome Pearls.
15 Mar, 2022 | 08:23h | UTC#326 NephMadness 2022: Cardiorenal Syndrome – The Curbsiders
Comprehensive quality of life outcomes with invasive vs. conservative management of chronic coronary disease in the ISCHEMIA trial.
14 Mar, 2022 | 01:27h | UTCComprehensive Quality of Life Outcomes with Invasive versus Conservative Management of Chronic Coronary Disease in ISCHEMIA – Circulation (link to abstract – $ for full-text)
Original Articles:
ISCHEMIA Trial: Initial Invasive vs. Conservative Strategy for Stable Coronary Disease
ISCHEMIA Trial: Management of Coronary Disease in Patients with Advanced Kidney Disease
Commentary on Twitter
https://twitter.com/CircAHA/status/1502052947869503497
Practical, evidence-based approaches to nutritional modifications to reduce atherosclerotic cardiovascular disease.
14 Mar, 2022 | 01:25h | UTC
Target temperature management following cardiac arrest: a systematic review and Bayesian meta-analysis.
14 Mar, 2022 | 01:14h | UTCRelated:
ERC-ESICM guidelines on temperature control after cardiac arrest in adults.
Diagnostic test interpretation: cardiopulmonary exercise testing.
14 Mar, 2022 | 01:01h | UTCCardiopulmonary Exercise Testing – JAMA (free for a limited period)
Review: Electrical management of heart failure: from pathophysiology to treatment.
14 Mar, 2022 | 00:58h | UTCElectrical management of heart failure: from pathophysiology to treatment – European Heart Journal
Update on management of atrial fibrillation in heart failure: a focus on ablation.
14 Mar, 2022 | 00:57h | UTCUpdate on management of atrial fibrillation in heart failure: a focus on ablation – Heart
Commentary on Twitter
https://t.co/M9tKQXJWwe Update on management of atrial fibrillation in heart failure: a focus on ablation pic.twitter.com/flPdBMcHwM
— Heart_BMJ (@Heart_BMJ) June 15, 2021
Systematic Review: Antiplatelet agents for chronic kidney disease.
11 Mar, 2022 | 09:35h | UTCAntiplatelet agents for chronic kidney disease – Cochrane Library